FR2372175A1 - Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17 - Google Patents

Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17

Info

Publication number
FR2372175A1
FR2372175A1 FR7806455A FR7806455A FR2372175A1 FR 2372175 A1 FR2372175 A1 FR 2372175A1 FR 7806455 A FR7806455 A FR 7806455A FR 7806455 A FR7806455 A FR 7806455A FR 2372175 A1 FR2372175 A1 FR 2372175A1
Authority
FR
France
Prior art keywords
hydroxy
androstanone
preparation
androstene
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7806455A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2372175A1 publication Critical patent/FR2372175A1/fr
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/005Degradation of the lateral chains at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procédé de préparation de dérivés de l'androstanone-17 répondant à la formule générale V, dans laquelle la liai
FR7806455A 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17 Pending FR2372175A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
FR2372175A1 true FR2372175A1 (fr) 1978-06-23

Family

ID=5983514

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7721932A Granted FR2365588A1 (fr) 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17
FR7806455A Pending FR2372175A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7721932A Granted FR2365588A1 (fr) 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17

Country Status (18)

Country Link
US (1) US4179336A (fr)
JP (1) JPS5315493A (fr)
AT (1) AT363196B (fr)
BE (1) BE856860A (fr)
CH (3) CH627190A5 (fr)
CS (1) CS200517B2 (fr)
DD (4) DD136142A5 (fr)
DE (1) DE2632677A1 (fr)
DK (1) DK142372C (fr)
FR (4) FR2365588A1 (fr)
GB (1) GB1585786A (fr)
HU (4) HU182681B (fr)
IE (1) IE45304B1 (fr)
IT (1) IT1077339B (fr)
NL (1) NL7706638A (fr)
SE (1) SE440779B (fr)
SU (1) SU980628A3 (fr)
YU (1) YU164277A (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
JPH0512528Y2 (fr) * 1987-09-08 1993-03-31
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Shokubai Co., Ltd. Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
MXPA05007628A (es) * 2003-05-23 2005-10-19 Nektar Therapeutics Al Corp Derivados de polimeros que tienen arreglos de atomos particulares.
EP2495242B1 (fr) * 2009-10-29 2016-05-04 Industry-Academic Cooperation Foundation Yonsei University Nouvel inhibiteur de fuite vasculaire
WO2012116290A2 (fr) 2011-02-25 2012-08-30 Washington University Stéroïdes neuroactifs substitués par 17(20)-z-vinylcyano, promédicaments de ceux-ci et procédés de traitement les utilisant
EP3572417A3 (fr) 2011-10-14 2020-03-25 Sage Therapeutics, Inc. Composés de 19-nor prégnane disubstitués 3,3, compositions et leurs utilisations
MX365644B (es) 2012-12-18 2019-06-10 Univ Washington Esteroides neuroactivos sustituidos con 19-alcoxi-17, profarmacos de los mismos, y metodos de tratamiento usando los mismos.
EP2956466A4 (fr) * 2013-02-15 2016-11-02 Univ Washington Stéroïdes énantiomères neuroactifs susbtitués en position 15, 16 et 17, utilisés comme modulateurs de récepteurs gaba de type a
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
WO2014169831A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
RU2700264C2 (ru) 2013-04-17 2019-09-16 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
KR102239541B1 (ko) 2013-04-17 2021-04-14 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
EP3868382A1 (fr) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et leurs utilisations
LT3488852T (lt) 2013-08-23 2021-02-25 Sage Therapeutics, Inc. Neuroaktyvūs steroidai, kompozicijos, ir jų naudojimas
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
BR112017007902B1 (pt) 2014-10-16 2023-12-05 Sage Therapeutics, Inc Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
SI3224269T1 (sl) 2014-11-27 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
WO2020243488A1 (fr) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Stéroïdes neuroactifs et compositions associées

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2238220A1 (de) * 1971-08-06 1973-02-15 Searle & Co Verfahren zur herstellung von 3-(3beta, 17beta-dihydroxyandrost-5-en17alpha-yl)-propionsaeure-gamma-lacton

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (fr) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2238220A1 (de) * 1971-08-06 1973-02-15 Searle & Co Verfahren zur herstellung von 3-(3beta, 17beta-dihydroxyandrost-5-en17alpha-yl)-propionsaeure-gamma-lacton

Also Published As

Publication number Publication date
DK142372B (da) 1980-10-20
US4179336A (en) 1979-12-18
CH629222A5 (de) 1982-04-15
SE440779B (sv) 1985-08-19
JPS6117477B2 (fr) 1986-05-07
CS200517B2 (en) 1980-09-15
AT363196B (de) 1981-07-10
BE856860A (fr) 1978-01-16
HU182681B (en) 1984-02-28
JPS5315493A (en) 1978-02-13
DD136141A5 (de) 1979-06-20
FR2365588B1 (fr) 1982-06-25
ATA504677A (de) 1980-12-15
CH629503A5 (de) 1982-04-30
SU980628A3 (ru) 1982-12-07
DE2632677C2 (fr) 1988-06-16
IT1077339B (it) 1985-05-04
FR2372174A1 (fr) 1978-06-23
FR2365588A1 (fr) 1978-04-21
DD137235A5 (de) 1979-08-22
SE7708192L (sv) 1978-01-17
HU179344B (en) 1982-10-28
DK142372C (da) 1981-03-23
DE2632677A1 (de) 1978-01-26
HU182789B (en) 1984-03-28
IE45304L (en) 1978-01-16
DD136142A5 (de) 1979-06-20
FR2372176A1 (fr) 1978-06-23
NL7706638A (nl) 1978-01-18
HU182790B (en) 1984-03-28
YU164277A (en) 1982-08-31
GB1585786A (en) 1981-03-11
DD132439A5 (de) 1978-09-27
DK323677A (da) 1978-01-17
CH627190A5 (fr) 1981-12-31
IE45304B1 (en) 1982-07-28

Similar Documents

Publication Publication Date Title
FR2372175A1 (fr) Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
OA05725A (fr) Procédé de préparation de dérivés d'acides hydroxy-aminophosphonique hydrocarbonés.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
FR2428052A1 (fr) Nouveaux derives de 5-fluoro-(b-uridine ou 2'-desoxy-b-uridine), procede pour les preparer et agents carcinostatiques les renfermant
FR2386544A1 (fr) Procede pour la preparation de derives d'imidazodiazepine
FR2355797A1 (fr) Procede de preparation de vinylcyclopropanes substitues utilisables dans la preparation d'insecticides
FR2377367A1 (fr) Procede de preparation d'alcoxy-cetones
FR2415097A1 (fr) Derives de l'anthraquinone, leur procede de preparation et leur utilisation
FR2370020A2 (fr) Procede de preparation d'alkylphenols
OA06122A (fr) Procédé de préparation d'un nouveau dérivé de pyridine.
FR2354339A1 (fr) Procede de preparation d'acides 1-aminoalcane-1,1-diphosphoniques
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
FR2385670A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
FR2397387A1 (fr) 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
FR2391204A1 (fr) Derives de l'anthraquinone, leur procede de preparation et leur application a la teinture de matieres plastiques
FR2369288A1 (fr) Procede de preparation de composes organiques d'etain
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
FR2374292A1 (fr) Derives de l'acide 2,5-dihydroxybenzoique et applications a titre de medicament
FR2395258A1 (fr) Procede pour la preparation de phenylalkylsulfones
OA06879A (fr) Procédé de préparation de dérivés d'hétéroprostaglandines.
FR2368465A1 (fr) Procede de preparation de dichloronitranilines
FR2366298A1 (fr) Procede de preparation de derives de rifamycine p et q
FR2355811A1 (fr) Preparation de derives cyanes de cyclopropane